Tumor necrosis factor and isolated hepatic perfusion: from preclinical tumor models to clinical studies.
de Vries
Mark R
MR
Department of Surgical Oncology, Erasmus Medical Center-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. devries(a)-hlkd.azr.ni
ten Hagen
Timo L M
TL
Marinelli
Andreas W K S
AW
Eggermont
Alexander M M
AM
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000379:methods*; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D006801:Humans; D008099:Liver / Q000098:blood supply; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy* / Q000556:secondary; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D014409:Tumor Necrosis Factor-alpha